We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
These Companies Are Raising Guidance This Earnings Season
Read MoreHide Full Article
Key Takeaways
The 2026 Q1 earnings season continues to roll along, with a wide variety of companies reporting.
Both UNH and DGX have raised their current year outlooks, reflecting nice business momentum.
The 2026 Q1 earnings season continues to roll along, with a wide variety of companies revealing results in the coming days. The cycle, while still a bit in its early phase, has overall been strong, with growth remaining solid and a decent number of companies exceeding quarterly expectations.
And concerning those exceeding quarterly expectations, UnitedHealth Group (UNH - Free Report) and Quest Diagnostics (DGX - Free Report) both raised their outlooks, with each also seeing a nice pop following their results.
UnitedHealth Bounces Back
UnitedHealth posted a double beat relative to our consensus expectations, with both EPS and sales moving modestly higher year-over-year. It reflected the company’s first double-beat in several quarters, helping underpin the favorable reaction shares enjoyed post-earnings.
The company’s EPS outlook remains bullish, with estimates drifting higher across all timeframes illustrated below. The favorable revisions are led by a guidance upgrade, with UNH raising its FY26 earnings outlook.
Image Source: Zacks Investment Research
Quest Diagnostics Posts Double Digit Growth
Quest Diagnostics similarly posted a double-beat relative to our consensus expectations, marking the sixth consecutive period in which it exceeded both EPS and sales expectations. Sales grew 9.2% from the year-ago period, whereas EPS grew by a double-digit 13.1% YoY.
The company raised both its EPS and sales guidance for its current FY26 amid the favorable results, with DGX also sporting a similarly strong revisions picture, as shown below.
Image Source: Zacks Investment Research
Bottom Line
Guidance upgrades are generally among the most bullish announcements a company can make, signaling that the outlook is even better than previously expected. Upgrades commonly lead to share outperformance, with both UnitedHealth (UNH - Free Report) and Quest Diagnostics (DGX - Free Report) seeing bullish share reactions following their results.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
These Companies Are Raising Guidance This Earnings Season
Key Takeaways
The 2026 Q1 earnings season continues to roll along, with a wide variety of companies revealing results in the coming days. The cycle, while still a bit in its early phase, has overall been strong, with growth remaining solid and a decent number of companies exceeding quarterly expectations.
And concerning those exceeding quarterly expectations, UnitedHealth Group (UNH - Free Report) and Quest Diagnostics (DGX - Free Report) both raised their outlooks, with each also seeing a nice pop following their results.
UnitedHealth Bounces Back
UnitedHealth posted a double beat relative to our consensus expectations, with both EPS and sales moving modestly higher year-over-year. It reflected the company’s first double-beat in several quarters, helping underpin the favorable reaction shares enjoyed post-earnings.
The company’s EPS outlook remains bullish, with estimates drifting higher across all timeframes illustrated below. The favorable revisions are led by a guidance upgrade, with UNH raising its FY26 earnings outlook.
Image Source: Zacks Investment Research
Quest Diagnostics Posts Double Digit Growth
Quest Diagnostics similarly posted a double-beat relative to our consensus expectations, marking the sixth consecutive period in which it exceeded both EPS and sales expectations. Sales grew 9.2% from the year-ago period, whereas EPS grew by a double-digit 13.1% YoY.
The company raised both its EPS and sales guidance for its current FY26 amid the favorable results, with DGX also sporting a similarly strong revisions picture, as shown below.
Image Source: Zacks Investment Research
Bottom Line
Guidance upgrades are generally among the most bullish announcements a company can make, signaling that the outlook is even better than previously expected. Upgrades commonly lead to share outperformance, with both UnitedHealth (UNH - Free Report) and Quest Diagnostics (DGX - Free Report) seeing bullish share reactions following their results.